Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Gout: HELP
Chris Storgard
Based on 8 articles published since 2008
||||
Expertise Level
The expertise of Chris Storgard ranks in the
  • Top 1.5%
  • ... of 10,280 published authors worldwide on Gout
  • ... from 2008 through 2019
  • ... based on contributions to 8 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    Miscellaneous institutions in San Diego      
2017
  • University of Auckland, Auckland, New Zealand. · University of Tasmania, Hobart, Tasmania, Australia. · University of California, San Diego. · University of Michigan, Ann Arbor. · Ardea Biosciences, Inc., San Diego, California. · AstraZeneca Pharmaceuticals, Gaithersburg, Maryland. · Hospital Universitario Cruces, Baracaldo, Spain. · Pubmed 28597604
  • Rhumatologie, Lariboisière Hospital, and Université Paris Diderot Sorbonne Cité, Paris, France. · Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA. · Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA. · Biometrics, Ardea Biosciences, Inc., San Diego, California, USA. · Research & Development, Ardea Biosciences, Inc., San Diego, California, USA. · Research & Development, AstraZeneca Pharmaceuticals, Gaithersburg, Maryland, USA. · Medical Affairs, Ardea Biosciences, Inc., San Diego, California, USA. · Service de rhumatologie, Université de Lausanne, Lausanne, Switzerland. · Pubmed 27821644
  • University of Alabama at Birmingham. · East-West Medical Research Institute, Honolulu, Hawaii. · Ardea Biosciences, San Diego, California. · AstraZeneca Pharmaceuticals, Gaithersburg, Maryland. · University of Chicago, Chicago, Illinois. · Pubmed 27564409
2016
  • Rheumatology Division, Hospital Universitario Cruces, Barakaldo, Spain. · Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA Gilead Sciences, Foster City, California, USA. · Ardea Biosciences, San Diego, California, USA. · Ardea Biosciences, San Diego, California, USA Receptos, San Diego, California, USA. · Pubmed 26742777
  • Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden. · Unit of Occupational and Environmental Medicine, Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Wilmington, DE, USA. · Ardea Biosciences, San Diego, CA, USA. · Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Madrid, Spain. · IMS Health, Alexandria, VA, USA. · IMS Health, Paris, France. · IMS Health, Vilvoorde, Belgium. · Pubmed 27230988
  • a Department of Internal Medicine , University of Michigan , Ann Arbor , MI , USA. · b Research & Development, Ardea Biosciences, Inc. , San Diego , CA , USA. · c Medical Affairs, Ardea Biosciences, Inc. , San Diego , CA , USA. · d Health Outcomes, Ardea Biosciences, Inc. , San Diego , CA , USA. · Pubmed 26578028
2015
  • Department of Medicine, University of Chicago Medicine, MC0930, 5841 S Maryland Ave, Chicago, IL 60637. Electronic address: · East-West Medical Research Institute, Honolulu, HI. · Harvard Medical School, Boston, MA; Gout and Crystal Arthropathy Center, Massachusetts General Hospital, Boston, MA. · Department of Medicine, University of Auckland, Auckland, New Zealand. · Clinical Research and Development, Ardea Biosciences Inc., San Diego, CA. · Medical Affairs, Ardea Biosciences, Inc., San Diego, CA, USA. · Biostatistics, Ardea Biosciences, Inc., San Diego, CA, USA. · Pubmed 26190562
Probable:    AstraZeneca      
2017
  • Department of Rheumatology, Technical University Dresden, Dresden. · Department of Internal Medicine II, University Medicine Berlin, Berlin, Germany. · Department of Medicine, University of Auckland, Auckland, New Zealand. · Global Medicines Development, Cardiovascular and Metabolic Diseases Clinical Development Unit, AstraZeneca Pharmaceuticals, Gaithersburg, MD. · Clinical Research and Development, Ardea Biosciences, Inc., San Diego, CA. · Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 29029210
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Chris Storgard in 2008-2019 about Gout:

  • Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study. 2017
  • Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial. 2017
  • Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). 2017
  • Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study). 2017
  • Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol. 2016
  • Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis. 2016
  • A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift. 2016
  • An open-label, 6-month study of allopurinol safety in gout: The LASSO study. 2015
Show List of Full Article Records
Google Searches

Learn more about Chris Storgard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in San Diego
AstraZeneca
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in San Diego
2017
  • University of Auckland, Auckland, New Zealand. · University of Tasmania, Hobart, Tasmania, Australia. · University of California, San Diego. · University of Michigan, Ann Arbor. · Ardea Biosciences, Inc., San Diego, California. · AstraZeneca Pharmaceuticals, Gaithersburg, Maryland. · Hospital Universitario Cruces, Baracaldo, Spain. · Pubmed 28597604
  • Rhumatologie, Lariboisière Hospital, and Université Paris Diderot Sorbonne Cité, Paris, France. · Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA. · Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA. · Biometrics, Ardea Biosciences, Inc., San Diego, California, USA. · Research & Development, Ardea Biosciences, Inc., San Diego, California, USA. · Research & Development, AstraZeneca Pharmaceuticals, Gaithersburg, Maryland, USA. · Medical Affairs, Ardea Biosciences, Inc., San Diego, California, USA. · Service de rhumatologie, Université de Lausanne, Lausanne, Switzerland. · Pubmed 27821644
  • University of Alabama at Birmingham. · East-West Medical Research Institute, Honolulu, Hawaii. · Ardea Biosciences, San Diego, California. · AstraZeneca Pharmaceuticals, Gaithersburg, Maryland. · University of Chicago, Chicago, Illinois. · Pubmed 27564409
2016
  • Rheumatology Division, Hospital Universitario Cruces, Barakaldo, Spain. · Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA Gilead Sciences, Foster City, California, USA. · Ardea Biosciences, San Diego, California, USA. · Ardea Biosciences, San Diego, California, USA Receptos, San Diego, California, USA. · Pubmed 26742777
  • Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden. · Unit of Occupational and Environmental Medicine, Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Wilmington, DE, USA. · Ardea Biosciences, San Diego, CA, USA. · Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Madrid, Spain. · IMS Health, Alexandria, VA, USA. · IMS Health, Paris, France. · IMS Health, Vilvoorde, Belgium. · Pubmed 27230988
  • a Department of Internal Medicine , University of Michigan , Ann Arbor , MI , USA. · b Research & Development, Ardea Biosciences, Inc. , San Diego , CA , USA. · c Medical Affairs, Ardea Biosciences, Inc. , San Diego , CA , USA. · d Health Outcomes, Ardea Biosciences, Inc. , San Diego , CA , USA. · Pubmed 26578028
2015
  • Department of Medicine, University of Chicago Medicine, MC0930, 5841 S Maryland Ave, Chicago, IL 60637. Electronic address: · East-West Medical Research Institute, Honolulu, HI. · Harvard Medical School, Boston, MA; Gout and Crystal Arthropathy Center, Massachusetts General Hospital, Boston, MA. · Department of Medicine, University of Auckland, Auckland, New Zealand. · Clinical Research and Development, Ardea Biosciences Inc., San Diego, CA. · Medical Affairs, Ardea Biosciences, Inc., San Diego, CA, USA. · Biostatistics, Ardea Biosciences, Inc., San Diego, CA, USA. · Pubmed 26190562
AstraZeneca
2017
  • Department of Rheumatology, Technical University Dresden, Dresden. · Department of Internal Medicine II, University Medicine Berlin, Berlin, Germany. · Department of Medicine, University of Auckland, Auckland, New Zealand. · Global Medicines Development, Cardiovascular and Metabolic Diseases Clinical Development Unit, AstraZeneca Pharmaceuticals, Gaithersburg, MD. · Clinical Research and Development, Ardea Biosciences, Inc., San Diego, CA. · Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 29029210
Yearly article counts 004310000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.